NCT03892616View on ClinicalTrials.gov

A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

July 3, 2019

Study Completion Date

July 3, 2019

Conditions
Healthy
Interventions
DRUG

BI 1358894 (B)

Tablet formulation 2 (TF2a), fed

DRUG

BI 1358894 (C)

Tablet formulation 2 (TF2a), fasted

DRUG

BI 1358894 (D)

Tablet formulation 2 (TF2b), fed

DRUG

BI 1358894 (E)

Tablet formulation 2 (TF2b), fasted

DRUG

BI 1358894 (A)

Tablet formulation 1 (TF1), fed

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03892616 - A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood | Biotech Hunter | Biotech Hunter